{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:07:32Z","timestamp":1774868852110,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H05435"],"award-info":[{"award-number":["JP16H05435"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K09708"],"award-info":[{"award-number":["JP16K09708"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17K16623"],"award-info":[{"award-number":["JP17K16623"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.yebeh.2018.03.010","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T23:23:35Z","timestamp":1523661815000},"page":"87-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Topiramate-induced weight loss depends on level of intellectual disability in patients with epilepsy"],"prefix":"10.1016","volume":"83","author":[{"given":"Hirotaka","family":"Iwaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-918X","authenticated-orcid":false,"given":"Mayu","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8164-4171","authenticated-orcid":false,"given":"Nobukazu","family":"Nakasato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunao","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2018.03.010_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2008.11.014","article-title":"Topiramate weight loss in migraine patients","volume":"278","author":"Alberici","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00023210-200317110-00002","article-title":"Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy","volume":"17","author":"Biton","year":"2003","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.yebeh.2018.03.010_bb0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/oby.2003.102","article-title":"A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity","volume":"11","author":"Bray","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diabres.2016.02.002","article-title":"Topiramate monotherapy for weight reduction in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"114","author":"Paravattil","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0025","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1517\/13543776.2013.790957","article-title":"Antiobesity carbonic anhydrase inhibitors: a literature and patent review","volume":"23","author":"Scozzafava","year":"2013","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1467-789X.2006.00296.x","article-title":"The prevalence and determinants of obesity in adults with intellectual disabilities","volume":"8","author":"Melville","year":"2007","journal-title":"Obes Rev"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.seizure.2003.12.001","article-title":"Changes in body mass index during long-term topiramate therapy in paediatric epilepsy patients\u2014a retrospective analysis","volume":"13","author":"Reiter","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0040","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0404.2008.01130.x","article-title":"Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy","volume":"119","author":"Schreiner","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2011.05.014","article-title":"Topiramate-induced weight loss: a review","volume":"95","author":"Verrotti","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0050","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/1744629516657946","article-title":"An examination of the nutritional intake and anthropometric status of individuals with intellectual disabilities: results from the SOPHIE study","volume":"21","author":"Hoey","year":"2017","journal-title":"J Intellect Disabil"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ridd.2013.10.012","article-title":"Overweight in intellectually-disabled population: physical, behavioral and psychological characteristics","volume":"35","author":"Mikulovic","year":"2014","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0060","first-page":"1007","article-title":"Possible association between moderate intellectual disability and weight gain in valproic acid-treated patients with epilepsy","volume":"11","author":"Tanamachi","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0065","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0070","doi-asserted-by":"crossref","first-page":"1402-8.e1","DOI":"10.1016\/j.jpeds.2013.06.081","article-title":"Parent support improves weight loss in adolescents and young adults with Down syndrome","volume":"163","author":"Curtin","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/oby.2000.84","article-title":"Topiramate reduces energy and fat gains in lean (Fa\/?) and obese (fa\/fa) Zucker rats","volume":"8","author":"Picard","year":"2000","journal-title":"Obes Res"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0080","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/oby.2003.78","article-title":"Predictors of weight loss in adults with topiramate-treated epilepsy","volume":"11","author":"Ben-Menachem","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0085","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/oby.2004.206","article-title":"Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects","volume":"12","author":"Astrup","year":"2004","journal-title":"Obes Res"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0090","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ridd.2011.10.011","article-title":"Physical activity levels in older adults with intellectual disabilities are extremely low","volume":"33","author":"Hilgenkamp","year":"2012","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.wnf.0000172994.56028.c3","article-title":"Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain","volume":"28","author":"Ko","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0100","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.ijo.0802783","article-title":"A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects","volume":"28","author":"Wilding","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ane.12373","article-title":"Effects of adjunctive zonisamide treatment on weight and body mass index in children with partial epilepsy","volume":"131","author":"Lagae","year":"2015","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"10.1016\/j.yebeh.2018.03.010_bb0110","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/dom.12275","article-title":"Weight changes in obese adults 6-months after discontinuation of double-blind zonisamide or placebo treatment","volume":"16","author":"Shin","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.yebeh.2018.03.010_bb0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.yebeh.2004.03.002","article-title":"Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center","volume":"5","author":"Bootsma","year":"2004","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018300829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018300829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T09:24:16Z","timestamp":1534929856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505018300829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":23,"alternative-id":["S1525505018300829"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.03.010","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topiramate-induced weight loss depends on level of intellectual disability in patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}